Abstract
Many articles during recent years have discussed the pharmacotherapy of hypertension in old age. Their counsels for elderly hypertensives run the gamut from ‘… hypotensive drugs… should hardly ever be used’ (Wedgwood, 1973) and ‘… diastolic pressures up to 120 mmHg… are not an indication for therapy’ (Jackson et al 1976) to ‘…management of hypertension above 150/90 should vary with the individual’ (Burch, 1975) and ‘… regardless of the patient’s age, systolic pressure above 160 mmHg and diastolic pressure above 95 mmHg should be treated’ (Chrysant, Frohlich and Papper, 1976). The one common feature of all these recommendations is their impressionistic nature. Although they tend to sound authoritative, such articles merely express the authors’opinions and are not based on any positive knowledge. They cannot possibly be, because the benefits and risks of pharmacological reduction of blood pressure in elderly hypertensives have not been established through controlled studies.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Alderman, M. H. (1977). High blood pressure: do we really know whom to treat and how? New Engl. J. Med, 296, 753–55
Alderman, M. H. and Yano, K. (1976). How prevalence of hypertension varies as diagnostic criteria change. Am. J. med. Sci, 271, 343–49
Amery, A. and De Schaepdrijver, A. (1975). Should elderly hypertensives be treated? Lancet, i, 272–73
Bender, A. D. (1965). The effect of increasing age on the distribution of peripheral blood flow in man. J. Am. Geriat. Soc, 13, 192–98
Brandfonbreuer, M., Landowne, M. and Shock, N. W. (1955). Changes in cardiac output with age. Circulation, 12, 557–66
Burch, G. E. (1975). Interesting aspects of geriatric cardiology. Am. Heart J, 89, 99–114
Carey, R. M., Reid, R. A., Ayers, C. R., Lynch, S. S., McLain, W. L. III and Vaughan, E. D.,Jr. (1976). The Charlottesville blood pressure study: value of repeated blood pressure measurements. J. Am. med. Ass, 236, 847–51
Castleden, C. M., Kaye, C. M. and Parsons, R. L. (1975). The effect of age on plasma levels of propranolol and practolol in man. Br. J. clin. Pharmac, 2, 303–6
Chrysant, S. G., Frohlich, E. D. and Papper, S. C. (1976). Why hypertension is so prevalent in the elderly-and how to treat it. Geriatrics, 31, 101–8
Colandrea, M. A., Friedman, G. D., Nichaman, M. Z. and Lynd, C. S. (1970). Systolic hyper- tension in the elderly: an epidemiologic assessment. Circulation, 41, 239–45
Cooper, E. S. and West, J. W. (1977). Hypertension and stroke. Cardiovasc. Med, 2, 429–44 Crooks, J., O’Malley, K. and Stevenson, I. H. (1976). Pharmacokinetics in the elderly. Clin.Pharmacokin, 1, 280–96
Davison, W. (1972). Unwanted drug effects in the elderly. In Drug-Induced Diseases, Vol. 4 (ed. L. Meyler and H. M. Peck ), Excerpta Medica, Amsterdam, pp. 617–36
Dustan, H. P. (1974). Atherosclerosis complicating chronic hypertension. Circulation, 50, 871–79
Editorial (1977). Hypertension in the elderly. Lancet, i, 684–85
Eisalo, A., Heino, A. and Munter, J. (1974). The effect of alprenolol in elderly patients with raised blood pressure. Acta med. stand, Suppl. 554, 23–31
Farah, F., Taylor, W., Rawlins, M. D. and James, O. (1977). Hepatic drug acetylation and oxidation: effects of aging in man. Br. med. J, 2, 155–56
Feinstein, A. R. (1974). The derangements of the `range of normal’. Clin. Pharmac. Ther, 15, 528–40
Fishback, D. B. (1976). An approach to the treatment of hypertension in the aged. Angiology, 27, 212–18
Freis, E. D. (1972). Hypertension: a controllable disease. Clin. Pharmac. Ther, 13, 627–32
Friedman, S. A., Raizner, A. E., Rosen, H., Solomon, N. A. and Sy, W. (1972). Functional defects in the aging kidney. Ann. int. Med, 76, 41–45
Gorrod, J. W. (1974). Absorption, metabolism and excretion of drugs in geriatric subjects. Gerontol. Clin, 16, 30–42
Goss, L. Z., Rosa, R. M. F. and O’Brien, W. M. (1969). Predicting death from renal failure in primary hypertension. Archs intern. Med, 124, 160–64
Greenblatt, D. J., Duhme, D. W., Allen, M. D. and Koch-Weser, J. (1977). Clinical toxicity of furosemide in hospitalized patients. A report from the Boston Collaborative Drug Surveillance Program. Am. Heart J, 94, 6–13
Greenblatt, D. J. and Koch-Weser, J. (1973a). Adverse reactions to spironolactone. A report from the Boston Collaborative Drug Surveillance Program. J. Am. med. Ass, 225, 40–43
Greenblatt, D. J. and Koch-Weser, J. (1973b). Adverse reactions to propranolol in hospitalized medical patients. A report from the Boston Collaborative Drug Surveillance Program. Am. Heart J, 86, 478–84
Gubner, R. S. (1962). Systolic hypertension: a pathogenic entity. Significance and therapeutic considerations. Am. J. Cardiol, 9, 773–76
Hall, M. R. P. (1973). Drug therapy in the elderly. Br. med. J, 3, 582–84
Hallock, P. and Benson, I. C. (1937). Studies on the elastic properties of human isolated aorta. J. clin. Invest, 16, 595–602
Hamilton, M., Thompson, E. N. and Wisniewski, T. K. M. (1964). The role of blood pressure control in preventing complications of hypertension. Lancet, i, 235–38
Hansen, J. M., Kampmann, J. and Laursen, M. (1970). Renal excretion of drugs in the elderly. Lancet, i, 1170
Harris, R. (1970). The Management of Geriatric Cardiovascular Disease, Lippincott, Philadelphia
Ho, J. K„ Lin, L. Y. and Galysh, F. T. (1972). Aortic compliance: studies on its relationship to aortic constituents in man. Archs Path, 94, 537–46
Hypertension Detection and Follow-Up Program Cooperative Group (1977). The hypertension detection and follow-up program. A progress report. Circ. Res, 40, Suppl. 1, 106–9
Hypertension-Stroke Cooperative Study Group (1974). Effect of antihypertensive treatment on stroke recurrence. J. Am. med. Ass, 229, 409–18
Jackson, G., Pierscianowski, T. A., Mahon, W. and Condon, J. (1976). Inappropriate antihypertensive therapy in the elderly. Lancet, ii, 1317–18
Johnsson, G. and Regardh, C.-G. (1976). Clinical pharmacokinetics of 3-adrenoreceptor blocking drugs. Clin. Pharmacokin, 1, 233–63
Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure (1977). Report of the committee. J. Am. med. Ass, 237, 255–61
Kannel, W. B. (1974). Role of blood pressure in cardiovascular morbidity and mortality. Prog. Cardiovasc. Dis, 17, 5–24
Kannel, W. B., Castelli, W. P., McNamara, P. M., McKee, P. A. and Feinleib, M. (1972). Role of blood pressure in the development of congestive heart failure. The Framingham study. New Engl. J. Med, 287, 781–87
Kannel, W. B., Dawber, T. R., Sorlie, P. and Wolf, P. A. (1976). Components of blood pressure and risk of atherothrombotic brain infarction: the Framingham study. Stroke, 7, 327–31
Kannel, W. B. and Gordon, T. (eds.) (1974). The Framingham Study. An Epidemiologic Investi-gation of Cardiovascular Disease. U. S. Government Printing Office, Washington, D. C.
Kannel, W. B., Gordon, T. and Offutt, D. (1969). Left ventricular hypertrophy by electro-cardiogram: prevalence, incidence and mortality in the Framingham study. Ann. intern.Med, 71, 89–105
Kannel, W. B., Gordon, T. and Schwartz, M. J. (1971). Systolic versus diastolic blood pressure and risk of coronary heart disease: the Framingham study. Am. J. Cardiol, 27, 335–46
Kannel, W. B., Wolf, P. A., Verter, J. and McNamara, P. M. (1970). Epidemiologic assessment of the role of blood pressure in stroke: the Framingham study. J. Am. med. Ass, 214, 301–10
Koch-Weser, J. (1973a); Correlation of pathophysiology and pharmacotherapy in primary hypertension. Am. J. Cardiol, 32, 499–510
Koch-Weser, J. (1973b). The therapeutic challenge of systolic hypertension. New Engl. J. Med, 289, 481–83
Koch-Weser, J. (1974a). Vasodilator drugs in the treatment of hypertension. Arch. intern. Med, 133, 1017–27
Koch-Weser, J. (1974b). Individualization of antihypertensive drug therapy. Med. Clin. North Am, 58, 1027–36
Koch-Weser, J. (1975). Drug interactions in cardiovascular therapy. Am. Heart J, 90, 93–116 Koch-Weser, J. (1976a). Hydralazine. New Engl. J. Med, 295, 320–23
Koch-Weser, J. (1976b). Modern approaches to the treatment of hypertension. In Clinical Pharmacy and Pharmacology (ed. W. A. Gouveia, G. Tognoni and E. v. d. Kleijn ), Elsevier/North Holland Biomedical Press, Amsterdam, pp. 93–104
Koch-Weser, J. and Sellers, E. M. (1976). Binding of drugs to serum albumin. New Engl. J. Med, 294, 311–16, 526–31
Lindeman, R. D., Bouthilet, G. N., Ashley, W. R. and Morris, J. R. (1963). Effect of hydro-chlorothiazide-reserpine therapy on cerebral function in elderly hypertensives. J. Am. Geriat. Soc, 2, 597–606
Lundborg, P. and Steen, B. (1976). Plasma levels and effect on heart rate and blood pressure of metoprolol after acute oral administration in 12 geriatric patients. Acta med. stand.., 200, 397–402
MacFarlane, I. F. R. and Kennedy, R. D. (1973). Clinical experience with amiloride in the elderly. Acta Cardiol, 28, 365–74
Master, A. M. (1952). Normal Blood Pressure and Hypertension, Lea and Febiger, Philadelphia
Master, A. M. and Lasser, R. P. (1961). Blood pressure elevation in the elderly. In Hypertension:Recent Advances (ed. A. N. Brest and J. H. Moyer ), Lea and Febiger, Philadelphia, pp. 24–34
Meyer, J. S., Sawada, R., Kitamura, A. and Toyoda, M. (1968). Cerebral blood flow after con-trol of hypertension in stroke. Neurology, 18, 772–81
Miall, W. E. and Chinn, S. (1974). Screening for hypertension: some epidemiologic observations. Br. med. J, 3, 595–600
O’Malley, K., Crooks, J., Duke, E. and Stevenson, I. H. (1971). Effect of age and sex on human drug metabolism. Br. med. J, 3, 607–9
O’Malley, K., Judge, T. G. and Crooks, J. (1976). Geriatric clinical pharmacology and thera-peutics. In Drug Treatment (ed. G. S. Avery ), Adis Press, Sidney, pp. 123–42
Page, L. P. and Sidd, J. J. (1972). Medical management of arterial hypertension. New Engl. J.Med, 287, 960–67
Papper, S. (1973). The effects of age in reducing renal function. Geriatrics, 28, 83–87
Paul, O. (1971). Risks of mild hypertension: a ten-year report. Br. Heart J, 33 (suppl.), 116–21
Perry, H. M. (1977). Treatment of mild hypertension. Preliminary results of a two-year feasi-bility trial. Circ. Res, 40, suppl. 1, 180–87
Pfeifer, H. J., Greenblatt, D. J. and Koch-Weser, J. (1976). Clinical toxicity of reserpine in hospitalized patients. A report from the Boston Collaborative Drug Surveillance Program. Am. J. med. Sei, 271, 269–76
Pfeifer, H. J., Greenblatt, D. J. and Koch-Weser, J. (1977). Adverse reactions to practolol in hospitalized patients. A report from the Boston Collaborative Drug Surveillance Program. Eur. J. clin. Pharmac, 12, 167–70
Proger, S. (1972). Antihypertensive drugs: praise and restraint. New Engl. J. Med, 286, 155–56
Ramirez, E. A. and Pont, P. H. G. (1965). Relation of arterial blood pressure to the transverse diameter of the heart in compensated hypertensive heart disease. Circulation, 31, 542–50
Richey, D. P. and Bender, A. D. (1977). Pharmacokinetic consequences of aging. A. Rev.Pharmac. Tox, 17, 49–65
Seligman, A. W., Alderman, M. H., Engelland, A. L. and Davis, T. K. (1977). Treatment of systolic hypertension. Clin. Res, 25, 254A
Smith, W. M. (1977). Treatment of mild hypertension. Results of a ten-year intervention trial. Circulation Res, 40, suppl. 1, 98–105
Society of Actuaries (1959). Build and Blood Pressure Study. Chicago
Strandgaard, S. (1976). Autoregulation of cerebral blood flow in hypertensive patients. Circulation, 53, 720–27
Tarazi, R. C., Magrini, F. and Dustan, H. P. (1975). The role of aortic distensibility in hypertension. In Advances in Hypertension, Vol. II (ed. P. Milliez and M. Safar ), Boehringer, Ingelheim, pp. 133–42
Triggs, E. J. and Nation, R. L. (1975). Pharmacokinetics in the aged: a review. J. Pharmacokin. Biopharm, 3, 387–418
Triggs, E. J., Nation, R. L., Long, A. and Ashley, J. J. (1975). Pharmacokinetics in the elderly. Eur. J. clin. Pharmac, 8, 55–62
United States National Center for Health Statistics (1977). Blood pressure levels of persons 6–74 years of age in the United States. Government Printing Office, Series II, No. 203, Rockville, Maryland
Veterans Administration Cooperative Study Group on Antihypertensive Agents (1967). Effects of treatment on morbidity in hypertension. Results in patients with diastolic blood pressures averaging 115 to 129 mmHg. J. Am. med. Ass, 202, 1028–34
Veterans Administration Cooperative Study Group on Antihypertensive Agents (1970): Effects of treatment on morbidity in hypertension. II. Results in patients with diastolic blood pressure averaging 90 through 114 mmHg. J. Am. med. Ass, 213, 1143–52
Veterans Administration Cooperative Study Group on Antihypertensive Agents (1972). Effects of treatment on morbidity in hypertension. III. Influence of age, diastolic pressure and prior cardiovascular disease; further analysis of side effects. Circulation, 45, 991–1004
Wedgwood, J. (1973). Cardiovascular disease in the old. Br. med. J., 3, 622–26
Zacest, R., Gilmore, E. and Koch-Weser, J. (1972). Treatment of essential hypertension with combined vasodilation and beta-adrenergic blockade. New Engl. J. Med, 286, 617–22
Zacest, R. and Koch-Weser, J. (1972). Relation of propranolol plasma level to beta-blockade during oral therapy. Pharmacology, 7, 178–84
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Copyright information
© 1979 J. Crooks and I. H. Stevenson
About this chapter
Cite this chapter
Koch-Weser, J. (1979). Treatment of hypertension in the elderly. In: Crooks, J., Stevenson, I.H. (eds) Drugs and the Elderly. Palgrave Macmillan, London. https://doi.org/10.1007/978-1-349-03813-8_23
Download citation
DOI: https://doi.org/10.1007/978-1-349-03813-8_23
Publisher Name: Palgrave Macmillan, London
Print ISBN: 978-1-349-03815-2
Online ISBN: 978-1-349-03813-8
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)